» Articles » PMID: 17573774

Impairment of the Ubiquitin-proteasome System by Cellular FLIP

Overview
Journal Genes Cells
Date 2007 Jun 19
PMID 17573774
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular FLIP (cFLIP) is a homologue of caspase-8 without protease activity that inhibits the apoptosis signaling initiated by death receptor ligation. We previously reported that a long form of cFLIP (cFLIP-L) inhibits ubiquitylation of beta-catenin and enhances Wnt signaling. Here we show that cFLIP-L impairs the function of the ubiquitin-proteasome system (UPS), and increases the accumulation of various short-lived proteins, such as GFP conjugated with destabilization sequence, beta-catenin and HIF1 alpha, that are subjected to rapid ubiquitylation and degradation by proteasomes. Accordingly, beta-catenin- and HIF1 alpha-mediated gene expressions are induced in the cFLIP-L-expressing cells. Exogenously expressed cFLIP-L accumulates in aggregates at the peri-nuclear region in the cells, and the cFLIP-L aggregates are refractory to solubilization. Like exogenously expressed cFLIP-L, the endogenous cFLIP in A549 lung cancer cells displays particulate distribution in the cells and more than 60% of cFLIP-L is refractory to solubilization. Down-regulation of cFLIP in A549 cells by RNA-mediated interference reduced beta-catenin- and HIF1 alpha-mediated gene expression. These results suggest that cFLIP-L is prone to aggregate and impairs UPS function, which could be involved in the pathological function of cFLIP-L expressed in certain cancer cells.

Citing Articles

Regulated cell death in glioma: promising targets for natural small-molecule compounds.

Han M, Li S, Fan H, An J, Peng C, Peng F Front Oncol. 2024; 14:1273841.

PMID: 38304870 PMC: 10830839. DOI: 10.3389/fonc.2024.1273841.


c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.

Wang W, Shang Y, Wang C, Ni J, Wang A, Li G Acta Pharmacol Sin. 2022; 43(11):2956-2966.

PMID: 35422085 PMC: 9622852. DOI: 10.1038/s41401-022-00905-7.


FLIP(L) is critical for aerobic glycolysis in hepatocellular carcinoma.

Lei S, Yang J, Chen C, Sun J, Yang L, Tang H J Exp Clin Cancer Res. 2016; 35:79.

PMID: 27178057 PMC: 4865989. DOI: 10.1186/s13046-016-0358-3.


FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP.

Tsuchiya Y, Nakabayashi O, Nakano H Int J Mol Sci. 2015; 16(12):30321-41.

PMID: 26694384 PMC: 4691174. DOI: 10.3390/ijms161226232.


Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.

French R, Hayward O, Jones S, Yang W, Clarkson R Mol Cancer. 2015; 14:209.

PMID: 26667821 PMC: 4678708. DOI: 10.1186/s12943-015-0478-y.